Remdesivir added to COVID-19 Invitation for Expression of Interest (EOI) M Announcement 29 March, 2022 - 13:40 (CEST) Remdesivir invited for COVID-19:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published M Announcement 29 March, 2022 - 13:00 (CEST) New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published Addition under section:
List of WHO Prequalification Evaluating Laboratories updated IVD Announcement 28 March, 2022 - 15:59 (CEST)
WHO list of prequalified in vitro diagnostic products updated IVD Alerts 25 March, 2022 - 18:00 (CET)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 22 March, 2022 - 13:00 (CET)